Staphylococcus aureus and its Effects on the Prognosis of Bronchiectasis

Microb Drug Resist. 2021 Jun;27(6):823-834. doi: 10.1089/mdr.2020.0352. Epub 2020 Nov 24.

Abstract

Bronchiectasis, which is an abnormal and irreversible dilation of one or several bronchial segments, causes significant morbidity and impaired quality of life to patients, mainly as the result of recurrent and chronic respiratory infections. Staphylococcus aureus is a microorganism known for its high infectious potential related to the production of molecules with great pathogenic power, such as enzymes, toxins, adhesins, and biofilm, which determine the degree of severity of systemic symptoms and can induce exacerbated immune response. This review highlighted the clinical significance of S. aureus colonization/infection in bronchiectasis patients, since little is known about it, despite its increasing frequency of isolation and potential serious morbidity.

Keywords: S. aureus, virulence factors; antimicrobial resistance; bronchiectasis.

Publication types

  • Review

MeSH terms

  • Adhesins, Escherichia coli / genetics
  • Adhesins, Escherichia coli / metabolism
  • Bacterial Toxins / metabolism
  • Biofilms / growth & development
  • Bronchiectasis / complications*
  • Bronchiectasis / mortality
  • Exotoxins / metabolism
  • Humans
  • Leukocidins / metabolism
  • Methicillin-Resistant Staphylococcus aureus / genetics
  • Methicillin-Resistant Staphylococcus aureus / physiology
  • Microbiota / physiology
  • Prognosis
  • Staphylococcal Infections / etiology*
  • Staphylococcus aureus / genetics
  • Staphylococcus aureus / physiology*
  • Superantigens / immunology

Substances

  • Adhesins, Escherichia coli
  • Bacterial Toxins
  • Exotoxins
  • Leukocidins
  • Panton-Valentine leukocidin
  • Superantigens